The benefits of antibiotics are well known, but the risks are not. In this video, Christian Lillis, son of Peggy Lillis, shares his personal story of losing his mother to ...

There is strong evidence that host immune response to C. difficile toxin A has a substantial role in determining clinical outcome of infection and some cases of CDAD that are related to toxin B ...

The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Medically reviewed by Robert Burakoff, MD Irritable bowel syndrome (IBS) is a combination of digestive symptoms, including ...

Researchers in Colorado are using words like “catastrophic” and “bombshell” to describe the potential impact of the 15 ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

Fidaxomicin resistance in vivo has not been reported. [45–48] Cross-resistance among fidaxomicin, macrolides, β-lactams, lincosamides, aminoglycosides, and rifampin has also not been observed ...

Three dairy veterinarians, including one who worked only in states with no known bird flu outbreaks in cows, had recent, ...

The Centers for Disease Control and Prevention removed certain information on its website to comply with President Trump’s ...